Product Details
| Sequence: | ~30 kDa |
| |
| Source: | Produced in E. coli. |
| |
| UniProt ID: | P62258 |
| |
| Formulation: | Liquid. In 20 mM Tris-HCl, pH 8, containing 100 mM NaCl. |
| |
| Purity: | ≥90% (SDS-PAGE) |
| |
| Purity Detail: | Purified by multi-step chromatography |
| |
| Application Notes: | Drug screening, protein-protein interaction studies, gel overlays. |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. |
| |
| Scientific Background: | 14-3-3 proteins are dimeric phosphoserine/phosphothreonine binding proteins, which have been shown to be involved in the regulation of many crucial processes such as signal transduction, cell-cycle control, apoptosis, protein localization, phosphorylation state and stability, transcription, metabolism, and malignant transformation. 14-3-3ε is implicated in an early left-right patterning in amphibian embryos. In addition, children with Miller-Dieker syndrome, a severe brain malformation associated with mental retardation, have heterozygous deletions of both the 14-3-3ε and LIS1 genes. It has also been shown to be the only 14-3-3 isoform associated with prion protein amyloid deposits of Gerstmann-Straussler-Scheinker disease. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Activation of innate immunity by 14-3-3 ϵ, a new potential alarmin in osteoarthritis: M. Millerand, et al.; Osteoarthritis Cartilage
28, 646 (2020),
Abstract;
Related Products
